Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Bromopyrimidine >  7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE

7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE

Basic information Uses Safety Supplier Related

7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE Basic information

Product Name:
7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE
Synonyms:
  • 7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE
  • 7-bromothieno[3,2-d]pyrimidin-4(3H)-one
  • 7-bromothieno[3,2-d]pyrimidin-4-ol
  • 7-BroMo-3H-thieno[3,2-d]pyriMidin-4-one
  • 7-broMo-1H,4H-thieno[3,2-d]pyriMidin-4-one
  • 7-bromo-3H,4H-thieno[3,2-d]pyrimidin-4-one
  • Thieno[3,2-d]pyrimidin-4(3H)-one, 7-bromo-
  • 7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE ISO 9001:2015 REACH
CAS:
31169-25-2
MF:
C6H3BrN2OS
MW:
231.07
EINECS:
1308068-626-2
Mol File:
31169-25-2.mol
More
Less

7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE Chemical Properties

Boiling point:
452.7±30.0 °C(Predicted)
Density 
2.18
storage temp. 
Sealed in dry,Room Temperature
form 
solid
pka
10.19±0.20(Predicted)
Appearance
Off-white to light brown Solid
More
Less

7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONE Usage And Synthesis

Uses

7-Bromothieno[3,2-D]pyrimidine-4(1H)-one is a useful research chemical for organic synthesis and other chemical processes.

Synthesis

16234-10-9

31169-25-2

The general procedure for the synthesis of 7-bromothieno[3,2-d]pyrimidin-4(1H)-one from thieno[3,2-d]pyrimidin-4(3H)-one (38.0 g, 0.25 mol) was as follows: a dilution of bromine (40.4 mL, 0.78 mol) in acetic acid (122 mL, 2.1 mol) was slowly added to a thieno[3,2-d]pyrimidin -4(3H)-one solution in acetic acid (143 mL, 2.5 mol). The reactor was sealed and the reaction mixture was stirred at 120°C for 18 hours. Upon completion of the reaction, the mixture was cooled to room temperature and the acetic acid was subsequently removed by distillation under reduced pressure. The concentrate was poured into ice water and precipitate was precipitated, which was filtered and dried to afford the target compound 7-bromothieno[3,2-d]pyrimidin-4(1H)-one (37.5 g, 65% yield) without further purification. The product was characterized by 1H-NMR (300 MHz, DMSO-d6): δ 12.75 (brs, 1H), 8.36 (s, 1H), 8.24 (s, 1H).

References

[1] Patent: WO2014/3483, 2014, A1. Location in patent: Page/Page column 19
[2] Patent: US2014/371219, 2014, A1. Location in patent: Paragraph 0204; 0205
[3] Patent: US2006/4002, 2006, A1. Location in patent: Page/Page column 38
[4] Patent: WO2011/25940, 2011, A1. Location in patent: Page/Page column 83
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 6, p. 2869 - 2881

7-BROMOTHIENO[3,2-D]PYRIMIDIN-4(1H)-ONESupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com
SpringPharma Tech Co.,Ltd
Tel
+86-25-68710855, +86-25-68710897
Email
sales@springpharma.net
Chiba Pharmaceutical Science and technology Co, Ltd.
Tel
0531-81313138 13066006660
Email
chibapharm@foxmail.com
Nanjing Norris-Pharm Technology Co., Ltd
Tel
18652989687
Email
sales@norris-pharm.com